Enovis Corporation (ENOV): Orthopedic Innovation and Growth Potential Drive Analyst Confidence

Enovis Corporation (NYSE:ENOV) is one of the best cheap stocks poised to skyrocket. On January 6, BTIG initiated coverage of Enovis Corporation (NYSE:ENOV) with a Buy rating and a $41 price target. The positive stance underscores the research firm’s confidence about the company’s long-term prospects as it offers a range of orthopedic care from prevention to surgical and post-surgical recovery.

The company has consistently delivered mid-single-digit to high-single-digit organic revenue growth in its Reconstruction and Prevention & Recovery segments. The research firm is projecting accelerated growth in 2026 as the company launches clinically meaningful new products across Extremities, Hips, and Knees. The higher-growth Reconstruction business is also expected to drive margins, as the mature Prevention & Recovery segment delivers steady cash flow.

Earlier, on January 5, UBS lowered its price target for the stock to $50 from $57, while maintaining the Buy rating. The price target cut came on the heels of the research firm’s sales projections of $2.26 billion in 2025, $2.37 billion in 2026, and $2.52 billion in 2027. Additionally, the firm expects new and ramping product launches in ARVIS to accelerate growth, mirroring the company’s growing cash flow generation.

Enovis Corporation (NYSE:ENOV) is a global medical technology company that develops and sells clinically differentiated solutions for musculoskeletal health, focusing on improving patient outcomes in areas like reconstruction, rehabilitation, and pain management through orthopedic devices, surgical implants, and related technologies.

While we acknowledge the potential of ENOV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Top 10 Materials Stocks to Buy According to Analysts and 10 Best Organic Food and Farming Stocks to Buy Now.

Disclosure: None. This article is originally published at Insider Monkey.